Avicanna Welcomes Initial U.S. Rescheduling of Medical Cannabis & Provides Scientific Update
The proposed rescheduling of cannabis to Schedule III represents a regulatory milestone that could unlock rigorous clinical research previously restricted under Schedule I classification. This change would enable pharmaceutical-grade development pathways…
Federal Cannabis Reform in Motion: What Businesses Need to Know | Ice Miller – JDSupra
Federal cannabis reform medical implications extend beyond policy headlines to real clinical practice considerations. Healthcare providers and patients must navigate evolving regulations while maintaining focus on evidence-based medical cannabis care.…
Proposed rule would allow for creation of marijuana research facilities in Missouri
✦ New CED Clinical Relevance #70Notable Clinical Interest Emerging findings or policy developments worth monitoring closely. ⚒ Cannabis News | CED Clinic Research InfrastructureClinical…
Griffith University’s new-look CBD campus unveiled – Newsreel
✦ New CED Clinical Relevance #70Notable Clinical Interest Emerging findings or policy developments worth monitoring closely. ⚒ Cannabis News | CED Clinic Medical EducationResearch…
Forest Service to close 57 research stations, including 6 in California – SFGATE
✦ New CED Clinical Relevance #70Notable Clinical Interest Emerging findings or policy developments worth monitoring closely. ⚒ Cannabis News | CED Clinic Research InfrastructurePolicyEnvironmental…
CU Boulder, CSU join forces to share research facilities
✦ New CED Clinical Relevance #70Notable Clinical Interest Emerging findings or policy developments worth monitoring closely. ⚒ Cannabis News | CED Clinic Research InfrastructureAcademic…
Blood donor biobank pipeline to collect genome-based samples for research – Nature
✦ New CED Clinical Relevance #70Notable Clinical Interest Emerging findings or policy developments worth monitoring closely. ⚒ Cannabis News | CED Clinic GenomicsResearch InfrastructurePersonalized…